Search - tctmd.com

Displaying 41 - 60 of 96

Sort: Relevancy | Date

News Daily News

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Todd Neale

September 21, 2015

News Daily News

Registry Data Show Low Complication Rates With Open Surgical Access for Transfemoral TAVR

Todd Neale

September 14, 2015

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

News Daily News

Study Explores Safety of Early Discharge After Transfemoral TAVR

L.A. McKeown

June 24, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Industry News

Essential Medical Inc. Announces Successful Additional Clinical Studies For MANTA™ Large Bore Vascular Closure Device

May 04, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

News Daily News

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景(1)

February 19, 2015

News Daily News

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景

Salynn Boyles

February 19, 2015

News Daily News

Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis

February 19, 2015

News Daily News

La Valvuloplastia Mejora el Pronóstico a Corto Plazo de Pacientes con Estenosis Aórtica Tratada Médicamente

February 19, 2015

News Daily News

Early Discharge After Transfemoral TAVR Safe in Selected Patients

Yael L. Maxwell

February 09, 2015

News Daily News

PARTNER Analysis Looks at Predictors, Clinical Impact of Pacemaker Implantation

January 28, 2015

News Daily News

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

January 12, 2015

News Daily News

PARTNER Registry Documents Strides Made in Transfemoral TAVR

L.A. McKeown

December 04, 2014

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Daily News

Preexisting Thrombocytopenia Worsens Complications After TAVR

L.A. McKeown

October 16, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Industry News

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

September 13, 2014

Advertisement

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Registry Data Show Low Complication Rates With Open Surgical Access for Transfemoral TAVR

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

Study Explores Safety of Early Discharge After Transfemoral TAVR

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Essential Medical Inc. Announces Successful Additional Clinical Studies For MANTA™ Large Bore Vascular Closure Device

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景(1)

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景

Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis

La Valvuloplastia Mejora el Pronóstico a Corto Plazo de Pacientes con Estenosis Aórtica Tratada Médicamente

Early Discharge After Transfemoral TAVR Safe in Selected Patients

PARTNER Analysis Looks at Predictors, Clinical Impact of Pacemaker Implantation

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

PARTNER Registry Documents Strides Made in Transfemoral TAVR

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Preexisting Thrombocytopenia Worsens Complications After TAVR

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content